SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-23-052650
Filing Date
2023-10-11
Accepted
2023-10-11 17:25:20
Documents
1
Period of Report
2023-10-06

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4188
  Complete submission text file 0001209191-23-052650.txt   5609
Mailing Address ONE KENDALL SQUARE, BUILDING 200 SUITE 2 CAMBRIDGE MA 02139
Business Address
Cunningham, Richard Anthony (Reporting) CIK: 0001624783 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40388 | Film No.: 231321377

Mailing Address JFL CAPITAL MANAGEMENT 1017 RR 620 S, SUITE 107 LAKEWAY TX 78734
Business Address JFL CAPITAL MANAGEMENT 1017 RR 620 S, SUITE 107 LAKEWAY TX 78734 737 203 5270
Anebulo Pharmaceuticals, Inc. (Issuer) CIK: 0001815974 (see all company filings)

IRS No.: 851170950 | State of Incorp.: DE | Fiscal Year End: 0630
SIC: 2834 Pharmaceutical Preparations